Researchers worldwide are using mass cytometry to provide unprecedented high-parameter phenotyping and Imaging Mass Cytometry™ (IMC™) to enable high-dimensional spatial visualization of complex cellular phenotypes and their relationships in the context of the tissue microenvironment.
There are hundreds of mass cytometry peer-reviewed publications to explore, covering a wide range of application areas—immunology, immuno-oncology, oncology and immune-mediated diseases and more. And the number of IMC publications is at more than 45 and climbing.
In Exploring the Tissue and Tumor Microenvironment: A Review of Recent Mass Cytometry and Imaging Mass Cytometry Publications, see one-slide publication reviews from several recent publications.
Here are a few documents and links that will help you identify the publications that could provide a meaningful background for your current work.
Trending Now is a quarterly anthology of recent impactful publications by researchers using CyTOF® technology to help expand our understanding of human health and disease.
Learn why it could be a significant advantage to replace immunohistochemistry with IMC in this publication review with commentary on the clinical pathology of a critical COVID-19 patient.
Get More Information
Mass Cytometry: See how you can achieve unprecedented high-parameter phenotyping.
Imaging Mass Cytometry: Learn how IMC enables high-dimensional spatial visualization of complex cellular phenotypes and their relationships in the context of tissue and tumor microenvironments.
Therapeutic Insights Services: Learn how our expert consultants can work with you to tailor and execute a sample-to-answer project designed for your specific needs for single-cell mass cytometry or IMC data.
Fluidigm respects your privacy.